Tiger Brokers

AU StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

4DMEDICAL LTD

3.340
-0.140-4.02%
Volume:2.12M
Turnover:7.15M
Market Cap:2.01B
PE:-9.76
High:3.440
Open:3.410
Low:3.310
Close:3.480
52wk High:7.550
52wk Low:1.400
Shares:601.57M
Float Shares:377.76M
Volume Ratio:0.83
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.342
EPS(LYR):-0.342
ROE:-174.43%
ROA:-15.62%
PB:11.81
PE(LYR):-9.76

Loading ...

OverviewCompanyNewsFilings

Is 4DMedical’s (ASX:4DX) CT:VQ Push and Index Debut Reframing Its Risk‑Reward Profile?

Simply Wall St.
·
May 12

Is 4DMedical’s (ASX:4DX) GSK Imaging Deal a Clue to Its Evolving Business Model?

Simply Wall St.
·
May 03

A Look At 4DMedical’s Valuation After New GlaxoSmithKline Imaging Contract

Simply Wall St.
·
May 01

4DMedical's Year-to-Date Fiscal 2026 Operating Revenue Rises 12% Year on Year

MT Newswires Live
·
Apr 30

4DMedical Says State Street Becomes Substantial Holder

MT Newswires Live
·
Apr 28

A Look At 4DMedical’s (ASX:4DX) Valuation After Its New GlaxoSmithKline Lung Imaging Contract

Simply Wall St.
·
Apr 24

Is 4DMedical's (ASX:4DX) ASX 200 Debut a Turning Point in Its Risk Narrative?

Simply Wall St.
·
Apr 22

BRIEF-4Dmedical Executes Contract With Glaxosmithkline For Lung Imaging Analytics

Reuters
·
Apr 20

4DMedical Secures One-Year Deal With GlaxoSmithKline

MT Newswires Live
·
Apr 20

Stock Track | 4DMedical Soars 8.22% Intraday on GSK Contract, UK Certification, and ASX 200 Inclusion

Stock Track
·
Apr 20

4DMedical Ltd - Ct:Vq Receives Ukca Certification for Clinical Use in United Kingdom

THOMSON REUTERS
·
Apr 20

4DMedical Ltd-GSK Contract, UK Clearance for Ctvq, and ASX 200 Inclusion

THOMSON REUTERS
·
Apr 20

4DMedical Ltd - Executes Contract With Glaxosmithkline for Lung Imaging Analytics

THOMSON REUTERS
·
Apr 20

ASX Biggest Losers

MT Newswires Live
·
Apr 17

S&P Dow Jones Indices: Insignia Financial Limited to Be Removed From the S&P/ASX 200 Index

THOMSON REUTERS
·
Apr 13

A Look At 4DMedical (ASX:4DX) Valuation After CE Mark Milestone For CT:VQ In Europe

Simply Wall St.
·
Apr 11

Stock Track | 4DMedical Soars 5.26% Intraday Following EU Regulatory Approval and A$83 Million Capital Raise

Stock Track
·
Apr 08

EU CT:VQ Approval And A$83m Raise Might Change The Case For Investing In 4DMedical (ASX:4DX)

Simply Wall St.
·
Apr 07

Assessing 4DMedical (ASX:4DX) Valuation After CE Mark Approval And A$83 Million Equity Raise

Simply Wall St.
·
Apr 04

4DMedical wins EU CE Mark approval for CT:VQ lung imaging software

Reuters
·
Mar 30
More